OakChart

Health In Tech Inc

HITTechnology·Software - Application·USA·Nano·NASD·Nov 11 • 3:59 PM ET

0.5595-0.0342 (-5.76%)
2026-11-12 06:42 CET
Market cap
36.54 USD m
Revenue, TTM
32.83 USD m
Net income, TTM
-3.95 USD m
Free cash flow, TTM
-5.11 USD m
EPS diluted, TTM
-0.07
P/E
-
Compare

Price

HIT against its 20, 50 and 200-day averages
2050200missearnings
0.501.001.502.003.1M6.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HITclose 0.5620-day 0.5950-day 0.74200-day 1.120.56

80.4% under the 52-week high of 2.85 on 11 Nov 2025. 52-week low 0.49 on 5 Nov 2026. Last 15 sessions, 40.2% high to low

Volume 0.39× normal · the line is the 50-bar volume average

Profile

HIT
52-week range, 3% of the way up
0.492.85

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

Employees91
IPODec 23, 2024
Beta2.97
ATR, 14d0.08
Rel volume0.39
Short float3.46%
Insider own73.35%
Inst own7.24%

Snapshot

6 groups

Valuation

Index-
Market Cap36.54M
Enterprise Value30.20M
Income-3.95M
Sales32.83M
Book/sh0.30
Cash/sh0.10
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees91
IPODec 23, 2024

Ratios

P/E-
Forward P/E-
PEG-
P/S1.11
P/B1.88
P/C5.61
P/FCF-
EV/EBITDA-
EV/Sales0.92
Quick Ratio2.17
Current Ratio2.17
Debt/Eq0.01
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.07
EPS next Y-0.00
EPS next Q-0.05
EPS this Y-966.66%
EPS next Y98.08%
EPS next 5Y-
EPS past 3/5Y145.52% -
Sales past 3/5Y79.42% -
EPS Y/Y TTM-362.10%
Sales Y/Y TTM22.98%
EPS Q/Q-453.98%
Sales Q/Q-13.50%
EarningsNov 12 AMC
EPS/Sales Surpr.-49.81% 4.08%

Ownership

Insider Own73.35%
Insider Trans-0.10%
Inst Own7.24%
Inst Trans64.09%
ROA-14.79%
ROE-21.96%
ROIC-20.18%
Gross Margin53.93%
Oper. Margin-17.22%
Profit Margin-12.03%
SMA20-5.30%
SMA50-24.61%
SMA200-49.94%
Trades-

Technical

Shs Outstand53.86M
Shs Float17.40M
Short Float3.46%
Short Ratio3.45
Short Interest0.60M
52W High2.85 -80.37%
52W Low0.49 13.71%
Volatility16.45% 13.79%
ATR (14)0.08
RSI (14)39.23
Beta2.97
Rel Volume0.39
Avg Volume174.54K
Volume67,476

Performance

Perf Week-6.36%
Perf Month-17.48%
Perf Quarter-47.22%
Perf Half Y-63.67%
Perf YTD-64.81%
Perf Year-73.98%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price3.12
Prev Close0.59
Price0.56
Change %-5.76%

Peers

Mkt cap
TickerCompanyMkt cap
ALITAlight Inc329.45M
EHTHeHealth Inc14.78M
SLQTSelectQuote Inc90.98M
HQYHealthequity Inc8.52B
CRVLCorvel Corp4.24B
XGPUReliance Global Group Inc3.29M
LIFEEthos Technologies Inc2.45B
GSHDGoosehead Insurance Inc1.64B
TWFGTWFG Inc1.46B
BWINBaldwin Insurance Group Inc4.48B

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Hasan Zain SyedChief Growth OfficerNov 03 '26Sale0.551,667917171,993Nov 05 04:30 PM
Hasan Zain SyedChief Growth OfficerOct 16 '26Sale0.623,3332,066173,660Oct 19 07:04 PM
Hayes TimothyDirectorSep 14 '26Sale0.8912,00010,716108,780Sep 15 04:05 PM
Hayes TimothyDIRECTORSep 14 '26Proposed Sale0.9012,00010,776Sep 14 04:42 PM
Hayes TimothyDIRECTORSep 10 '26Proposed Sale0.9217,73016,363Sep 14 11:19 AM
Hasan Zain SyedChief Growth OfficerSep 11 '26Sale0.9211,66710,734188,544Sep 14 08:55 AM
Hayes TimothyDirectorSep 11 '26Sale0.9112,00010,920120,780Sep 11 09:14 PM
Hayes TimothyDirectorSep 09 '26Sale0.935,7305,329132,780Sep 11 09:14 PM
Hasan Zain SyedChief Growth OfficerSep 11 '26Proposed Sale0.9418,33417,170Sep 10 11:24 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 142
  • Health In Tech Faces Cash And Credibility Test After Slashing 2026 Revenue Outlook (Earnings Whispers)
  • Health In Tech to Announce Third Quarter 2026 Financial Results on November 12, 2026 (PR Newswire) -5.89%
  • Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion (PR Newswire) -11.16%
  • Health In Tech to Host Annual Meeting of Stockholders (PR Newswire)
  • How Much Should This Move Change Your View Of Freshworks Stock? (Trefis)
  • Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement (PR Newswire)
  • Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference (PR Newswire) +6.15%
  • Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance (PR Newswire) -10.08%
  • Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026 (PR Newswire)
  • Health In Tech Inc (HIT) (Q2 2026) Earnings Call Highlights: Strategic Carrier Shift and Hitrix ... (GuruFocus.com) -5.19%
  • Health In Tech Reports Second Quarter 2026 Financial Results (PR Newswire)
  • Health In Tech Inc (HIT) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
  • Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026 (PR Newswire)
  • Health In Tech Added to Membership of Russell Microcap Index (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.053--7.963
2026Q22026-08-13-0.040-0.027-0.0408.107.783
2026Q12026-05-13-0.030-0.027-0.0288.807.453
2025Q42026-03-25-0.010-0.010-0.0057.517.262
2025Q32025-11-100.0100.0100.0088.497.051
2025Q22025-07-210.0100.0100.0119.317.492
2025Q12025-05-280.0150.0100.0098.018.001
2024Q42025-02-26-0.010--0.0035.00--
2026Q4---0.067--10.023
2027Q1---0.015--9.262
2027Q2---0.020--9.442
2027Q3---0.015--10.682
2027Q4---0.005--12.772

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY0.010-0.01219.00-
2025FY0.0200.0150.02033.3332.35
2026FY--0.173--34.85
2027FY--0.003--54.13

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-013037.966.3711.00
2026Q3S2026-09-303039.396.3711.00
2026Q3S2026-08-2530310.038.3011.00
2026Q3S2026-08-232029.558.3010.80
2026Q3S2026-08-1430211.518.3015.42
2026Q3S2026-08-1330012.6611.2715.42
2026Q3S2026-07-2830012.6611.2715.42
2026Q3S2026-06-0930112.6611.2715.42
2026Q3S2026-05-1431112.6611.2715.42
2026Q3S2026-04-1731012.7711.3015.42
2026Q3S2026-03-3021013.3611.3015.42
2026Q3S2026-03-2611011.3011.3011.30
2026Q3S2026-01-151018.808.808.80
2026Q3S2025-11-1210110.4010.4010.40

Estimate history

EPS, annual0.0020.0460.0120.022-0.0653
Period2022202320242025TTM
EPS, quarterly0.0060.007-0.0030.0090.0110.008-0.005-0.028-0.04
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual5.7719.15219.49133.32832.83
Period2022202320242025TTM
Sales, quarterly5.0024.4594.9058.0159.3148.497.5098.7728.057
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual54.06954.06954.61557.70665.558
Period2022202320242025MRQ
Shares, quarterly54.06954.06954.61554.67356.3856.48657.70665.55865.558
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Total Revenue32.8333.3319.4919.155.77
Cost of Goods Sold Incl. D&A15.1212.394.052.300.33
Gross Profit17.7020.9415.4416.855.44
Selling, General and Administrative Excl. Other23.3619.7914.4513.465.23
Research and Development2.251.572.812.000.79
Other Operating Expense0.000.000.000.000.00
Operating Income-5.651.150.993.380.21
Interest Expense0.000.000.49-0.00
Unusual Expense0.000.000.000.000.00
Net Income Before Taxes-5.231.670.893.420.20
Income Taxes-1.280.400.220.950.12
Consolidated Net Income-3.951.280.672.480.08
Net Income From Continuing Operations-3.951.280.671.000.40
Net Income-3.951.280.672.480.08
EPS (Recurring)-0.060.020.010.050.00
EPS (Basic, Before Extraordinaries)-0.070.020.010.050.00
EPS (Diluted)-0.070.020.010.050.00
EBITDA-4.302.051.533.720.21
Non-Operating Income (Expense)0.420.520.390.040.00
Other After Tax Adjustments0.000.000.000.000.00
Stock Option Compensation Expense-1.240.37--
Price To Earnings Ratio--159.38159.52-
Price To Sales Ratio1.932.7515.01--
Gross Margin53.9362.8279.2187.9794.21
Operating Margin-17.223.455.0817.663.56
Net Margin-12.033.843.4412.931.38
Shares Outstanding65.5657.7154.6154.0754.07
Market Capitalization36.5436.54289.54289.81-

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue8.068.777.518.499.318.014.904.46
Cost of Goods Sold Incl. D&A4.134.263.383.353.002.661.110.98
Gross Profit3.924.514.135.146.315.363.803.48
Selling, General and Administrative Excl. Other7.366.674.684.655.584.874.113.04
Research and Development0.880.920.210.240.580.540.630.72
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.44-2.16-0.550.490.730.48-0.320.44
Interest Expense0.000.000.000.000.000.00-0.17
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-3.32-2.07-0.440.600.830.68-0.110.41
Income Taxes-0.81-0.48-0.140.150.200.190.030.03
Consolidated Net Income-2.51-1.59-0.300.450.630.50-0.140.38
Net Income From Continuing Operations-2.51-1.59-0.300.450.630.50-0.140.38
Net Income-2.51-1.59-0.300.450.630.50-0.140.38
EPS (Recurring)-0.04-0.03-0.010.010.010.01-0.000.01
EPS (Basic, Before Extraordinaries)-0.04-0.03-0.010.010.010.01-0.000.01
EPS (Diluted)-0.04-0.03-0.010.010.010.01-0.000.01
EBITDA-3.12-1.75-0.140.710.860.62-0.180.57
Non-Operating Income (Expense)0.120.090.100.110.110.200.210.13
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-0.350.060.230.560.39--
Price To Earnings Ratio-64.4463.35131.5645.6053.36159.38159.52
Price To Sales Ratio1.932.442.726.141.831.6915.01-
Gross Margin48.6951.4154.9960.5967.7566.8277.4378.03
Operating Margin-42.68-24.60-7.305.817.786.00-6.459.84
Net Margin-31.17-18.11-4.035.336.776.22-2.948.43
Shares Outstanding65.5665.5657.7156.4956.3854.6754.6154.07
Market Capitalization36.5482.7690.48181.0148.1136.14289.54289.81

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY
Cash & Short Term Investments7.677.852.421.49
Short Term Receivables5.042.153.920.98
Inventories0.000.000.000.00
Other Current Assets3.280.790.2622.96
Total Current Assets15.9910.786.6025.43
Net Property, Plant & Equipment0.140.210.270.32
Total Investments and Advances0.000.000.000.00
Long-Term Note Receivable0.000.820.820.00
Intangible Assets6.533.963.562.76
Deferred Tax Assets0.540.050.000.06
Other Assets0.430.000.260.05
Total Assets23.6315.8211.5028.62
Short Term Debt Incl. Current Port. of LT Debt0.080.071.710.05
Accounts Payable4.191.862.620.47
Income Tax Payable0.000.210.450.12
Other Current Liabilities0.890.00-0.0023.37
Total Current Liabilities5.162.134.7824.02
Long Term Debt0.060.140.210.27
Provision for Risks Charges0.000.000.000.00
Deferred Tax Liabilities1.300.380.420.35
Other Liabilities0.000.000.000.00
Total Liabilities6.522.655.4124.64
Non-Equity Reserves0.000.000.000.00
Preferred Stock - Carrying Value0.000.000.002.57
Common Equity17.1113.176.091.05
Total Shareholders Equity17.1113.176.093.62
Accumulated Minority Interest0.000.000.000.37
Total Equity17.1113.176.093.98
Total Liabilities & Stockholders Equity23.6315.8211.5028.62
Book Value Per Share0.300.240.110.02
Tangible Book Value Per Share0.180.170.05-0.03
Full-Time Employees918083-
Price to Book Ratio1.8841.9141.95-
Return on Assets6.484.914.96-
Return on Equity8.456.9620.50-
Return on Invested Capital7.455.0439.312.05
Quick Ratio3.105.061.381.06
Current Ratio3.105.061.381.06

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Net Income-3.951.280.673.96-0.24
Depreciation1.350.900.540.340.00
Other Funds (Non Cash)5.775.760.90-0.020.57
Funds from Operations2.378.372.024.420.33
Extraordinary Item0.000.000.000.000.00
Changes in Working Capital-7.47-5.230.16-2.890.45
Income Taxes Payable-0.03-0.21-0.250.330.12
Cash from Operating Activities-5.113.132.181.530.78
Capital Expenditures-2.54-3.19-0.90-1.14-1.22
Net Assets From Acquisitions0.000.000.000.000.00
Sale of Fixed Assets and Businesses0.070.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.00
Purchase of Investments0.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.00
Other Uses0.000.000.00-0.800.00
Other Sources-0.060.060.000.00
Cash from Investing Activities-2.40-3.13-0.84-1.94-1.22
Cash Dividends Paid0.000.000.000.000.00
Change in Capital Stock6.30-0.196.240.002.00
Repurchase of Common Pref Stock0.000.000.000.000.00
Sale of Common Pref Stock6.30-0.196.240.002.00
Proceedsfrom Stock Options6.28-0.216.240.002.00
Issuance or Reduction of Debt, Net0.000.00-2.151.65-0.07
Change in Long Term Debt0.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.00
Net Financing Active Other Cash Flow-0.420.000.00-0.31-0.05
Other Financing Activities Uses-0.420.000.00-0.31-0.05
Cash from Financing Activities5.88-0.194.091.341.88
Net Change in Cash-1.62-0.185.430.931.44
Free Cash Flow-5.113.132.181.530.78
Preferred Dividends (Cash Flow)-0.000.000.00-
Price to Free Cash Flow-29.30134.39--
Deferred Taxes & Investment Tax Credit-0.43-0.090.130.01

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments6.5110.337.678.028.147.58
Short Term Receivables12.798.905.044.745.146.10
Inventories0.000.000.000.000.000.00
Other Current Assets2.382.863.282.121.511.80
Total Current Assets21.6822.0915.9914.8814.7915.48
Net Property, Plant & Equipment0.100.120.140.160.170.19
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets7.206.716.536.185.524.74
Deferred Tax Assets1.961.020.540.170.170.11
Other Assets0.110.050.430.670.850.09
Total Assets31.0629.9923.6322.9322.3421.44
Short Term Debt Incl. Current Port. of LT Debt0.080.080.080.070.070.07
Accounts Payable9.916.974.194.304.335.48
Income Tax Payable--0.000.000.030.43
Other Current Liabilities-0.000.000.890.870.960.78
Total Current Liabilities9.997.055.165.245.396.75
Long Term Debt0.020.040.060.080.100.12
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities1.421.291.300.440.430.40
Other Liabilities0.000.000.000.000.000.00
Total Liabilities11.438.386.525.775.927.28
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity19.5521.6017.1117.1616.4214.16
Total Shareholders Equity19.5521.6017.1117.1616.4214.16
Accumulated Minority Interest0.070.000.000.000.000.00
Total Equity19.6221.6017.1117.1616.4214.16
Total Liabilities & Stockholders Equity31.0629.9923.6322.9322.3421.44
Book Value Per Share0.300.330.300.300.290.26
Tangible Book Value Per Share0.190.230.180.190.190.17
Full-Time Employees--91---
Price to Book Ratio1.884.895.2311.023.402.74
Return on Assets-14.79-3.146.488.828.226.70
Return on Equity-21.96-4.528.4511.9411.8610.50
Return on Invested Capital-12.83-7.34-1.762.623.823.49
Quick Ratio2.173.133.102.842.742.29
Current Ratio2.173.133.102.842.742.29

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-2.51-1.59-0.300.450.630.50
Depreciation0.320.400.410.220.140.14
Other Funds (Non Cash)1.680.461.941.690.871.26
Funds from Operations-1.32-1.212.532.371.611.86
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.59-2.11-2.08-1.69-0.13-1.33
Income Taxes Payable0.000.000.00-0.03-0.390.22
Cash from Operating Activities-2.91-3.320.450.671.480.53
Capital Expenditures-0.60-0.36-0.83-0.74-0.91-0.70
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.070.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources--0.060.000.000.00
Cash from Investing Activities-0.53-0.36-0.77-0.74-0.91-0.70
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.046.34-0.04-0.04-0.01-0.10
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.046.34-0.04-0.04-0.01-0.10
Proceedsfrom Stock Options0.046.34-0.06-0.04-0.01-0.10
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.420.000.000.000.000.00
Other Financing Activities Uses-0.420.000.000.000.000.00
Cash from Financing Activities-0.376.34-0.04-0.04-0.01-0.10
Net Change in Cash-3.812.66-0.35-0.110.56-0.27
Free Cash Flow-2.91-3.320.450.671.480.53
Price to Free Cash Flow--28.8761.0913.6011.15

Revenue breakdown

HICard2024: 2.99M
Revenues From Underwriting Modeling ICE2024: 6.65M 2025: 10.76M
SMR2024: 9.95M 2025: 26.81M
United States2024: 19.59M 2025: 37.56M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.46%0.6M17.4M173.98K
2026-10-152.43%0.4M17.4M173.18K
2026-09-302.39%0.4M17.1M157.63K
2026-09-153.00%0.6M20.5M74.45K
2026-08-312.16%0.4M20.3M102.63K
2026-08-142.44%0.5M20.4M164.88K
2026-07-313.52%0.7M20.3M174.47K
2026-07-153.53%0.7M20.3M190.66K
2026-06-302.79%0.6M20.3M199.51K
2026-06-155.26%1.1M20.3M376.04K
2026-05-297.36%0.7M9.2M378.86K
2026-05-157.16%0.6M7.8M334.33K
2026-04-3011.24%0.9M7.8M325.04K
2026-04-1510.90%0.8M7.6M336.06K
2026-03-314.54%0.3M7.6M362.04K
2026-03-135.98%0.5M7.6M275.32K
2026-02-272.43%0.2M7.6M348.42K
2026-02-131.94%0.1M7.6M378.03K
2026-01-302.14%0.2M7.6M453.08K
2026-01-156.09%0.5M7.6M477.70K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-068-KCurrent report2026-11-02SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-10-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-268-KCurrent report2026-10-20SEC
2026-10-224Statement of changes in beneficial ownership of securities2026-10-20SEC
2026-10-223Initial statement of beneficial ownership of securities2026-10-20SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-19424B3SEC
2026-10-168-KCurrent report2026-10-12SEC
2026-10-15EFFECTEffectiveness filing by commission orderSEC
2026-10-13ARSAnnual report to security holders. 2025-12-31SEC
2026-10-13DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-10SEC
2026-10-13S-3/ASEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-07SEC
2026-10-01PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-30SEC
2026-09-308-KCurrent report2026-09-30SEC
2026-09-29SCHEDULE 13GSEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-14144Filing for proposed sale of securities under Rule 144.SEC
2026-09-14144Filing for proposed sale of securities under Rule 144.SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-04S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11009171
2026-10002.07K1
2026-090037.70K4
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Whetstone Capital Advisors, LLC2.30%
Mink Brook Asset Management LLC1.73%
VANGUARD CAPITAL MANAGEMENT LLC0.87%
HEIGHTS CAPITAL MANAGEMENT, INC0.53%
BlackRock, Inc.0.53%
GEODE CAPITAL MANAGEMENT, LLC0.36%
CITADEL ADVISORS LLC0.27%
VANGUARD FIDUCIARY TRUST CO0.20%
STATE STREET CORP0.10%
NORTHERN TRUST CORP0.09%

Funds

Fund% owned
MEDIUM-DURATION BOND FUND1.49%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.62%
VANGUARD EXTENDED MARKET INDEX FUND0.24%
Fidelity Extended Market Index Fund0.18%
iShares Micro-Cap ETF0.10%
Fidelity Nasdaq Composite Index Fund0.05%
Fidelity Series Total Market Index Fund0.05%
Fidelity Total Market Index Fund0.03%
1290 VT Micro Cap Portfolio0.01%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. HIT. Cached 15 minutes.

Some panels did not load: ratings.